Wednesday, July 8, 2026

Patent intelligence · US

US 9783598

Compositions and methods for treating and preventing Staphylococcus aureus infections

granted A61KA61K2039/505A61K2300/00A61K38/12
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 11
Applicant portfolio 31
Patent details — US 9783598
Jurisdiction
US
Status
granted
Grant date
Oct 10, 2017
Expiration
Oct 5, 2037
Applicant
XBIOTECH INC.
Claims
10
CPC classes
A61K, A61K2039/505, A61K2300/00, A61K38/12
View on Google Patents ↗

Quick answer

US 9783598 (Compositions and methods for treating and preventing Staphylococcus aureus infections) is held by XBIOTECH INC.. Status: granted. Granted Oct 10, 2017. Expires Oct 5, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Applicant
XBIOTECH INC.
Grant date
Expiration
Claims
10
CPC classes
A61K, A61K2039/505, A61K2300/00, A61K38/12, A61K38/14, A61K39/085

More from XBIOTECH INC.

Related pharmaceutical patents in our USPTO index.

  1. US 12116405

    Arthritis treatment

    XBIOTECH INC. · Expires Oct 10, 2044

    granted
  2. US 11932688

    Treatment for neoplastic diseases

    XBIOTECH INC. · Expires Mar 14, 2044

    granted
  3. US 11773157

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    XBIOTECH INC. · Expires Sep 28, 2043

    granted
  4. US 11529298

    Cosmetic composition and its use, dermocosmetic formulation

    LUXBIOTECH FARMACÉUTICA LTDA · Expires Dec 15, 2042

    granted
  5. US 11523981

    Cosmetic composition and its use, dermocosmetic formulation

    LUXBIOTECH FARMACÉUTICA LTDA · Expires Dec 8, 2042

    granted
  6. US 11370831

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    XBIOTECH INC. · Expires Jun 23, 2042

    granted
  7. US 10577410

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    XBIOTECH INC. · Expires Feb 27, 2040

    granted
  8. US 10294296

    Treatment for neoplastic diseases

    XBIOTECH INC. · Expires May 16, 2039

    granted

Frequently asked questions

What is US patent 9783598?

US 9783598 (Compositions and methods for treating and preventing Staphylococcus aureus infections) is held by XBIOTECH INC.. Status: granted. Granted Oct 10, 2017. Expires Oct 5, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 9783598?

XBIOTECH INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 31 pharmaceutical patents for this assignee.

When does US 9783598 expire?

Our index shows an expiration date of Oct 5, 2037 (11 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.